Olema Pharmaceuticals (OLMA) Cash from Operations (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Cash from Operations data on record, last reported at 45987000.0 in Q1 2026.

  • On a quarterly basis, Cash from Operations fell 4.57% to 45987000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 148724000.0, a 19.14% decrease, with the full-year FY2025 number at 146716000.0, down 40.6% from a year prior.
  • Cash from Operations reached 45987000.0 in Q1 2026 per OLMA's latest filing, down from 38327000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for OLMA hit a ceiling of 17903000.0 in Q1 2022 and a floor of 45987000.0 in Q1 2026.
  • A 5-year average of 27226235.29 and a median of 26284000.0 in 2024 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: tumbled 197.13% in 2022, then grew 16.41% in 2023.
  • Tracing OLMA's Cash from Operations over 5 years: stood at 19711000.0 in 2022, then grew by 6.27% to 18476000.0 in 2023, then plummeted by 42.26% to 26284000.0 in 2024, then crashed by 45.82% to 38327000.0 in 2025, then dropped by 19.99% to 45987000.0 in 2026.
  • Business Quant data shows Cash from Operations for OLMA at 45987000.0 in Q1 2026, 38327000.0 in Q4 2025, and 34527000.0 in Q3 2025.